Volume 18, Issue 87 (9-2011)                   RJMS 2011, 18(87): 8-13 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shirani F, Sebt Rozati S M. Evaluation of pentoxifylline effect in treatment of Ankylosis Spondylitis patients referred to Hazrat Rasool Akram Hospital. RJMS 2011; 18 (87) :8-13
URL: http://rjms.iums.ac.ir/article-1-1828-en.html
Abstract:   (8862 Views)

  Background: Ankylosing spondylitis (AS) is a spondyloarthropathy of unknown etiology, with widespread effect on axial and peripheral skeleton. The aim of this study was determination of Pentoxifylline effect on BASDAI number of uncontrolled AS patients in Rasool-e-Akram hospital rheumatology clinic.

  Methods: This pilot study was performed on 30 patients with ankylosis spondylitis with BASDAI ≥ 4 without attention to previous medical treatment. Pentoxifylline tablets administered 400 mg TDS and patients evaluated at 6 and 12 weeks after treatment. Data were analyzed by Paired T test and p<0.05 was significant.

  Results: 30 patients (26 = Male (86.7%), 4 = Female (13.3%)) with Ankylosing spondylitis was evaluated. Mean age of patients was 32.42±8.14.

  mean ± standard deviation of BASDAInumber in our patients was 6.53±1.72 at baseline, which decreased to 5.17±1.58 at 6 weeks and 4.88±1.66 at 12 weeks of treatment.(P=0/000) Between BASDAI before and after treatment with Pentoxifylline differences was significant.

  Conclusion: Pentoxifylline can be advised for uncontrolled AS patients regardless of current or previous treatment.

Full-Text [PDF 309 kb]   (8808 Downloads)    
Type of Study: Research | Subject: Rheumatology

Add your comments about this article : Your username or Email:

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2023 CC BY-NC 4.0 | Razi Journal of Medical Sciences

Designed & Developed by : Yektaweb